A leader in the world of cellular therapies.
Cook MyoSite® is a leader in the regenerative medicine industry by advancing our own personalized investigational cell therapy products toward the market through extensive clinical trial experience.
x
Newsroom
FDA Grants RMAT Designation to Cook MyoSite's AMDC-USR
Dec. 17, 2020 — Cook MyoSite today announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to Cook MyoSite’s AMDC-USR investigational product for treatment of women with persistent or recurrent stress urinary incontinence (SUI) following surgical treatment.

OUR MISSION
Cook MyoSite’s mission is to make regenerative medicine a part of everyday medicine.
CLINICAL APPLICATIONS
Cook MyoSite creates specialized treatments for patients. These treatments use the patient’s own muscle cells in a unique procedure that begins and ends with the patient’s own body. Currently, this technology is being investigated in clinical trials and is not commercially available.